Antimicrobial resistance is resistance to multiple classes of antibiotics, which makes it extremely challenging to treat infections caused by such organisms.
News
Artificial intelligence (AI) is going to be highly instrumental in patient care in all medical specialties and will be highly relevant in eye care.
Dr Ala Moshiri provides an overview of current treatment options for diabetic macular oedema.
Jorge L. Alió, MD, PhD, FEBOphth, shared his pearls situations in which a patient presents with a cataract and corneal opacity at the European Society of Ophthalmology Conference, Prague.
Paracentral acute middle maculopathy can develop after excessive intake of caffeine and alcohol according to Obadah Moushmoush, MD.
Omnigen® may be an alternative treatment option for patients with a persistent corneal epithelial defect. The product provides a convenient and effective treatment that can be administered in an outpatient setting.
As more countries receive approval for the use of faricimab, patients are going to continue to have good visual outcomes
Scientists hope to develop novel AI solutions for the prediction of DPN using corneal OCT images.
The new company debuted with £96 million in funding to target retinal diseases.
The EACCME accreditation is renewed through 2025.
The trial is evaluating Oxurion’s novel plasma kallikrein (PKal) inhibitor THR-149 as a potential treatment for DME patients who respond suboptimally to anti-VEGF therapy.
RAFARM and BioNanoSim have entered into an agreement to create the company.
A look at how EDOF technology can be categorised into five types
Debate continues over the best way to apply treatment option
SOE holds a special place in its heart for the up-and-coming young ophthalmologists and is providing them a number of opportunities to hone their skills and establish professional contacts at this meeting.
Novel procedures may hold greater appeal for cataract and refractive surgeons
The European Society of Ophthalmology (SOE) 2023 Congress will convene from June 15 to 17 in Prague, Czech Republic.
Clinical ophthalmology efforts will target the 'busiest' outpatient speciality.
Dr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis
The country is home to 20% of biotechs headquartered in Europe.
Ground-breaking treatment for bullous keratopathy approved in Japan
Therapeutic has fewer adverse effects in patients with POAG and OHT, study results show
Early detection and diagnosis are key for these young patients
Accessibility obstacles could prevent those with sight loss from receiving support and care.
What ophthalmologists want patients to know ahead of UK bank holiday.
Growing evidence supports dual therapy to slow progression.
The countries join 15 other nations that have eliminated the disease.
Advertisement
Advertisement